focus -WSS

focus

author：comprehensive 2025-09-27 22:57:02 - browse：39727

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Flu, Covid vaccination rates decline, new survey data show

hotspot

WSS

Why sickle cell disease is getting the first CRISPR treatment

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Radiology is caught between AI's potential and concern for patients

Setback for rare diseases as Taysha Gene Therapies pulls back

Flu, Covid vaccination rates decline, new survey data show

Congress extends some pandemic preparedness programs

knowledge

focus

focus

Dobbs anniversary: the lost opportunity of abortion as health care

Experts study whether long Covid risk adds up with each reinfection

Trump demands the U.S. pay no more for drugs than other countries … again

Nobel honors Karikó and Weissman's enduring partnership

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Pfizer plans to depart BIO

As demand for Covid shots wanes, Moderna seeks its next success

The United States is paying nearly triple for new Covid vaccines

Hollywood unions extend contract negotiations for actors

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

explore

Lawsuit highlights wrinkle for disputes over surprise medical bills

What will Novo Nordisk's VC do with its influx of cash?

Pharma patents targeted by Biden in move to slash drug prices

What will Novo Nordisk's VC do with its influx of cash?

Nobel honors Karikó and Weissman's enduring partnership

CRISPR base editing slashes cholesterol levels in monkeys

explore

hotspot

focus

Wikipedia